Viral regulators of complement activation: Structure, function and evolution

Molecular Immunology

Volumn 61, Issue 2, 2014, Pages 89-99

  Ojha, Hina ^a   Panwar, Hemendra Singh ^a   Gorham, Ronald D ^b   Morikis, Dimitrios ^b   Sahu, Arvind ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

^b University of California Riverside   (United States)

Author keywords

Complement regulation; Herpesvirus; Immune evasion; Poxvirus; RCA; Viral evolution

Indexed keywords

COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B; PROTEIN; REGULATOR OF COMPLEMENT ACTIVATION PROTEIN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; COMPLEMENT SYSTEM; DISULFIDE BOND; GLYCOSYLATION; IMMUNE EVASION; IMMUNOMODULATION; INDEL MUTATION; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; STATIC ELECTRICITY; VIRUS VIRULENCE;

HERPESVIRIDAE; POXVIRIDAE;

COMPLEMENT REGULATION; HERPESVIRUS; IMMUNE EVASION; POXVIRUS; RCA; VIRAL EVOLUTION.;

ANIMALS; BIOLOGICAL EVOLUTION; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; HUMANS; PROTEIN BINDING; VIRAL PROTEINS;

EID: 84907598707     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.06.004     Document Type: Review

References (105)

1. Adamo J.E., Meseda C.A., Weir J.P., Merchlinsky M.J. Smallpox vaccines induce antibodies to the immunomodulatory, secreted vaccinia virus complement control protein. J. Gen. Virol. 2009, 90:2604-2608.
2. Ahmad M., Pyaram K., Mullick J., Sahu A. Viral complement regulators: the expert mimicking swindlers. Indian J. Biochem. Biophys. 2007, 44:331-343.
3. Ahmad M., Raut S., Pyaram K., Kamble A., Mullick J., Sahu A. Domain swapping reveals complement control protein modules critical for imparting cofactor and decay-accelerating activities in vaccinia virus complement control protein. J. Immunol. 2010, 185:6128-6137.
4. Albrecht J.C., Fleckenstein B. New member of the multigene family of complement control proteins in herpesvirus saimiri. J. Virol. 1992, 66:3937-3940.
5. Albrecht J.C., Nicholas J., Cameron K.R., Newman C., Fleckenstein B., Honess R.W. Herpesvirus saimiri has a gene specifying a homologue of the cellular membrane glycoprotein CD59. Virology 1992, 190:527-530.
6. Alcami A., Koszinowski U.H. Viral mechanisms of immune evasion. Trends Microbiol. 2000, 8:410-418.
7. Amet T., et al. CD59 incorporation protects hepatitis C virus against complement-mediated destruction. Hepatology 2012, 55:354-363.
8. Baker N.A., Sept D., Joseph S., Holst M.J., McCammon J.A. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:10037-10041.
9. Bernet J., Ahmad M., Mullick J., Panse Y., Singh A.K., Parab P.B., Sahu A. Disabling complement regulatory activities of vaccinia virus complement control protein reduces vaccinia virus pathogenicity. Vaccine 2011, 29:7435-7443.
10. Bernet J., Mullick J., Panse Y., Parab P.B., Sahu A. Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b. J. Virol. 2004, 78:9446-9457.
11. Blom A.M., Villoutreix B.O., Dahlback B. Mutations in alpha-chain of C4BP that selectively affect its factor I cofactor function. J. Biol. Chem. 2003, 278:43437-43442.
12. Bramley J.C., Davies A., Lachmann P.J. Herpesvirus saimiri CD59-baculovirus expression and characterisation of complement inhibitory activity. Biochem. Soc. Trans. 1997, 25:354S.
13. Bratke K.A., McLysaght A. Identification of multiple independent horizontal gene transfers into poxviruses using a comparative genomics approach. BMC Evol. Biol. 2008, 8:67.
14. Bratke K.A., McLysaght A., Rothenburg S. A survey of host range genes in poxvirus genomes. Infect. Genet. Evol. 2013, 14:406-425.
15. Brown N.P., Leroy C., Sander C. MView: a web-compatible database search or multiple alignment viewer. Bioinformatics 1998, 14:380-381.
16. Carroll M.C., Isenman D.E. Regulation of humoral immunity by complement. Immunity 2012, 37:199-207.
17. Cattaneo R. Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet. J. Virol. 2004, 78:4385-4388.
18. Cheung A.S., Kieslich C.A., Yang J., Morikis D. Solvation effects in calculated electrostatic association free energies for the C3d-CR2 complex and comparison with experimental data. Biopolymers 2010, 93:509-519.
19. Ciulla E., Emery A., Konz D., Krushkal J. Evolutionary history of orthopoxvirus proteins similar to human complement regulators. Gene 2005, 355:40-47.
20. Dunkelberger J.R., Song W.C. Role and mechanism of action of complement in regulating T cell immunity. Mol. Immunol. 2010, 47:2176-2186.
21. Edgar R.C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004, 32:1792-1797.
22. El Assaad A.M., Kieslich C.A., Gorham R.D., Morikis D. Electrostatic exploration of the C3d-FH4 interaction using a computational alanine scan. Mol. Immunol. 2011, 48:1844-1850.
23. Elde N.C., Child S.J., Eickbush M.T., Kitzman J.O., Rogers K.S., Shendure J., Geballe A.P., Malik H.S. Poxviruses deploy genomic accordions to adapt rapidly against host antiviral defenses. Cell 2012, 150:831-841.
24. Engel P., Angulo A. Viral immunomodulatory proteins: usurping host genes as a survival strategy. Adv. Exp. Med. Biol. 2012, 738:256-276.
25. Estep R.D., et al. Deletion of the monkeypox virus inhibitor of complement enzymes locus impacts the adaptive immune response to monkeypox virus in a nonhuman primate model of infection. J. Virol. 2011, 85:9527-9542.
26. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 1985, 39:783-791.
27. Fodor W.L., Rollins S.A., Biancocaron S., Rother R.P., Guilmette E.R., Burton W.V., Albrecht J.C., Fleckenstein B., Squinto S.P. The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity. J. Virol. 1995, 69:3889-3892.
28. Friedman H.M., Cohen G.H., Eisenberg R.J., Seidel C.A., Cines D.B. Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature 1984, 309:633-635.
29. Fu M., Deng R., Wang J., Wang X. Detection and analysis of horizontal gene transfer in herpesvirus. Virus Res. 2008, 131:65-76.
30. Furtado P.B., Huang C.Y., Ihyembe D., Hammond R.A., Marsh H.C., Perkins S.J. The partly folded back solution structure arrangement of the 30 SCR domains in human complement receptor type 1 (CR1) permits access to its C3b and C4b ligands. J. Mol. Biol. 2008, 375:102-118.
31. Girgis N.M., Dehaven B.C., Fan X., Viner K.M., Shamim M., Isaacs S.N. Cell surface expression of the vaccinia virus complement control protein is mediated by interaction with the viral A56 protein and protects infected cells from complement attack. J. Virol. 2008, 82:4205-4214.
32. Girgis N.M., Dehaven B.C., Xiao Y., Alexander E., Viner K.M., Isaacs S.N. The vaccinia virus complement control protein modulates adaptive immune responses during infection. J. Virol. 2010, 85:2547-2556.
33. Gorham R.D., Kieslich C.A., Morikis D. Electrostatic clustering and free energy calculations provide a foundation for protein design and optimization. Ann. Biomed. Eng. 2011, 39:1252-1263.
34. Harris C.L., Abbott R.J., Smith R.A., Morgan B.P., Lea S.M. Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55). J. Biol. Chem. 2005, 280:2569-2578.
35. Heeger P.S., Kemper C. Novel roles of complement in T effector cell regulation. Immunobiology 2012, 217:216-224.
36. Herbert A., O'leary J., Krych-Goldberg M., Atkinson J.P., Barlow P.N. Three-dimensional structure and flexibility of proteins of the RCA family - a progress report. Biochem. Soc. Trans. 2002, 30:990-996.
37. Holm L., Sander C. Database algorithm for generating protein backbone and side-chain co-ordinates from a C alpha trace application to model building and detection of co-ordinate errors. J. Mol. Biol. 1991, 218:183-194.
38. Hudson P.N., et al. Elucidating the role of the complement control protein in monkeypox pathogenicity. PLoS. One. 2012, 7:e35086.
39. Isaacs S.N., Kotwal G.J., Moss B. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:628-632.
40. Johnson J.B., Grant K., Parks G.D. The paramyxoviruses simian virus 5 and mumps virus recruit host cell CD46 to evade complement-mediated neutralization. J. Virol. 2009, 83:7602-7611.
41. Kapadia S.B., Levine B., Speck S.H., Virgin H.W. Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection. Immunity 2002, 17:143-155.
42. Kapadia S.B., Molina H., van B., Speck V., Virgin S.H.H.W. Murine gammaherpesvirus 68 encodes a functional regulator of complement activation. J. Virol. 1999, 73:7658-7670.
43. Kieslich C.A., Morikis D. The two sides of complement C3d: evolution of electrostatics in a link between innate and adaptive immunity. PLoS Comput. Biol. 2012, 8:e1002840.
44. Kieslich C.A., Morikis D., Yang J., Gunopulos D. Automated computational framework for the analysis of electrostatic similarities of proteins. Biotechnol. Prog. 2011, 27:316-325.
45. Kieslich C.A., Tamamis P., Gorham R.D., López de V.A., Sausman N., Archontis G., Morikis D. Exploring protein-ligand and protein-protein interactions in the immune system using molecular dynamics and continuum electrostatics. Curr. Phys. Chem. 2012, 2:324-343.
46. Kieslich C.A., Vazquez H., Goodman G.N., Lopez D.V., Morikis D. The effect of electrostatics on factor H function and related pathologies. J. Mol. Graph. Model 2011, 29:1047-1055.
47. Kirkitadze M.D., Henderson C., Price N.C., Kelly S.M., Mullin N.P., Parkinson J., Dryden D.T., Barlow P.N. Central modules of the vaccinia virus complement control protein are not in extensive contact. Biochem. J. 1999, 344(Pt 1):167-175.
48. Kotwal G.J., Isaacs S.N., Mckenzie R., Frank M.M., Moss B. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 1990, 250:827-830.
49. Krushkal J., Bat O., Gigli I. Evolutionary relationships among proteins encoded by the regulator of complement activation gene cluster. Mol. Biol. Evol. 2000, 17:1718-1730.
50. Lachmann P.J. The Control of Homologous Lysis. Immunol. Today 1991, 12:312-315.
51. Lambris J.D., Ricklin D., Geisbrecht B.V. Complement evasion by human pathogens. Nat. Rev. Microbiol. 2008, 6:132-142.
52. Liszewski M.K., Bertram P., Leung M.K., Hauhart R., Zhang L., Atkinson J.P. Smallpox inhibitor of complement enzymes (SPICE): regulation of complement activation on cells and mechanism of its cellular attachment. J. Immunol. 2008, 181:4199-4207.
53. Liszewski M.K., Leung M.K., Atkinson J.P. Membrane cofactor protein: importance of N- and O-glycosylation for complement regulatory function. J. Immunol. 1998, 161:3711-3718.
54. Liszewski M.K., Leung M.K., Hauhart R., Buller R.M., Bertram P., Wang X., Rosengard A.M., Kotwal G.J., Atkinson J.P. Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation. J. Immunol. 2006, 176:3725-3734.
55. Liszewski M.K., Leung M.K., Hauhart R., Fang C.J., Bertram P., Atkinson J.P. Smallpox inhibitor of complement enzymes (SPICE): dissecting functional sites and abrogating activity. J. Immunol. 2009, 183:3150-3159.
56. Lukacik P., et al. Complement regulation at the molecular level: the structure of decay-accelerating factor. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:1279-1284.
57. Mark L., Lee W.H., Spiller O.B., Proctor D., Blackbourn D.J., Villoutreix B.O., Blom A.M. The Kaposi's sarcoma-associated herpesvirus complement control protein mimics human molecular mechanisms for inhibition of the complement system. J. Biol. Chem. 2004, 279:45093-45101.
58. Mark L., Spiller O.B., Okroj M., Chanas S., Aitken J.A., Wong S.W., Damania B., Blom A.M., Blackbourn D.J. Molecular characterization of the rhesus rhadinovirus (RRV) ORF4 gene and the RRV complement control protein it encodes. J. Virol. 2007, 81:4166-4176.
59. Marti-Renom M.A., Stuart A.C., Fiser A., Sanchez R., Melo F., Sali A. Comparative protein structure modeling of genes and genomes. Annu. Rev. Biophys. Biomol. Struct. 2000, 29:291-325.
60. Mazumdar B., Kim H., Meyer K., Bose S.K., Di Bisceglie A.M., Ray R.B., Ray R. Hepatitis C virus proteins inhibit C3 complement production. J. Virol. 2012, 86:2221-2228.
61. Mckenzie R., Kotwal G.J., Moss B., Hammer C.H., Frank M.M. Regulation of complement activity by vaccinia virus complement-control protein. J. Infect. Dis. 1992, 166:1245-1250.
62. McWilliam H., Li W., Uludag M., Squizzato S., Park Y.M., Buso N., Cowley A.P., Lopez R. Analysis tool web services from the EMBL-EBI. Nucleic Acids Res. 2013, 41:W597-W600.
63. Miller C.G., Shchelkunov S.N., Kotwal G.J. The cowpox virus-encoded homolog of the vaccinia virus complement control protein is an inflammation modulatory protein. Virology 1997, 229:126-133.
64. Morgan B.P., Berg C.W., Harris C.L. "Homologous restriction" in complement lysis: roles of membrane complement regulators. Xenotransplantation 2005, 12:258-265.
65. Morikis D., Lambris J.D. The electrostatic nature of C3d-complement receptor 2 association. J. Immunol. 2004, 172:7537-7547.
66. Morikis D., Zhang L. An immunophysical study of the complement system: Examples for the pH dependence of protein binding and stability. J. Non-Cryst. Solids 2006, 352:4445-4450.
67. Mullick J., Bernet J., Panse Y., Hallihosur S., Singh A.K., Sahu A. Identification of complement regulatory domains in vaccinia virus complement control protein. J. Virol. 2005, 79:12382-12393.
68. Mullick J., Bernet J., Singh A.K., Lambris J.D., Sahu A. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) open reading frame 4 protein (kaposica) is a functional homolog of complement control proteins. J. Virol. 2003, 77:3878-3881.
69. Mullick J., Bernet J., Singh A.K., Sahu A. Kinetic analysis of the interactions of Kaposica, the Kaposi's sarcoma-associated herpesvirus open reading frame 4 protein, with human complement components C3b and C4b. Mol. Immunol. 2004, 41(2-3):283. (ref type: abstract).
70. Mullick J., Kadam A., Sahu A. Herpes and pox viral complement control proteins: 'the mask of self'. Trends Immunol. 2003, 24:500-507.
71. Mullick J., Singh A.K., Panse Y., Yadav V., Bernet J., Sahu A. Identification of functional domains in kaposica, the complement control protein homolog of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). J. Virol. 2005, 79:5850-5856.
72. Newsome T.P., Scaplehorn N., Way M. SRC mediates a switch from microtubule- to actin-based motility of vaccinia virus. Science 2004, 306:124-129.
73. Park H.J., et al. Using mutagenesis and structural biology to map the binding site for the Plasmodium falciparum merozoite protein PfRh4 on the human immune adherence receptor. J. Biol. Chem. 2014, 289:450-463.
74. Paterson S., et al. Antagonistic coevolution accelerates molecular evolution. Nature 2010, 464:275-278.
75. Persson B.D., Schmitz N.B., Santiago C., Zocher G., Larvie M., Scheu U., Casasnovas J.M., Stehle T. Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens. PLoS Pathog. 2010, 6:e1001122.
76. Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 2004, 25:1605-1612.
77. Pyaram K., Kieslich C.A., Yadav V.N., Morikis D., Sahu A. Influence of electrostatics on the complement regulatory functions of Kaposica, the complement inhibitor of Kaposi's sarcoma-associated herpesvirus. J. Immunol. 2010, 184:1956-1967.
78. Pyaram K., Yadav V.N., Reza M.J., Sahu A. Virus-complement interactions: an assiduous struggle for dominance. Future Virol. 2010, 5:709-730.
79. Rattan, A., Kasbe, R., Mullick, J., Sahu, A., 2013. The complement system as a viral target for immune evasion. In: Kishore, U., Nayak, A. (Eds.), Microbial Pathogenesis: Infection and Immunity, Landes Bioscience/Springer, Austin, pp. 1-27.
80. Reza M.J., Kamble A., Ahmad M., Krishnasastry M.V., Sahu A. Dissection of functional sites in herpesvirus saimiri complement control protein homolog. J. Virol. 2013, 87:282-295.
81. Ricklin D., Lambris J.D. Complement-targeted therapeutics. Nat. Biotechnol. 2007, 25:1265-1275.
82. Rosengard A.M., Liu Y., Nie Z., Jimenez R. Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:8808-8813.
83. 1 inactivates the alternative complement pathway. J. Immunol. 1998, 160:5596-5604.
84. Sahu A., Lambris J.D. Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics. Immunopharmacology 2000, 49:133-148.
85. Saifuddin M., Parker C.J., Peeples M.E., Gorny M.K., Zolla-Pazner S., Ghassemi M., Rooney I.A., Atkinson J.P., Spear G.T. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1. J. Exp. Med. 1995, 182:501-509.
86. Saitou N., Nei M. The neighbor-join method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 1987, 4:406-425.
87. Sfyroera G., Katragadda M., Morikis D., Isaacs S.N., Lambris J.D. Electrostatic modeling predicts the activities of orthopoxvirus complement control proteins. J. Immunol. 2005, 174:2143-2151.
88. Singh A.K., Yadav V.N., Pyaram K., Mullick J., Sahu A. Mapping of functional domains in Herpesvirus saimiri complement control protein homolog: the complement control protein domain 2 is the smallest structural unit displaying cofactor and decay-accelerating activities. J. Virol. 2009, 83:10299-10304.
89. Spiller O.B., Blackbourn D.J., Mark L., Proctor D.G., Blom A.M. Functional activity of the complement regulator encoded by Kaposi's sarcoma-associated herpesvirus. J. Biol. Chem. 2003, 278:9283-9289.
90. Spiller O.B., Mark L., Blue C.E., Proctor D.G., Aitken J.A., Blom A.M., Blackbourn D.J. Dissecting the regions of virion-associated Kaposi's sarcoma-associated herpesvirus complement control protein required for complement regulation and cell binding. J. Virol. 2006, 80:4068-4078.
91. Spiller O.B., Morgan B.P., Tufaro F., Devine D.V. Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells. Eur. J. Immunol. 1996, 26:1532-1538.
92. Spiller O.B., Robinson M., O'Donnell E., Milligan S., Morgan B.P., Davison A.J., Blackbourn D.J. Complement regulation by Kaposi's sarcoma-associated herpesvirus ORF4 protein. J. Virol. 2003, 77:592-599.
93. Takemoto M., Yamanishi K., Mori Y. Human herpesvirus 7 infection increases the expression levels of CD46 and CD59 in target cells. J. Gen. Virol. 2007, 88:1415-1422.
94. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 2011, 28:2731-2739.
95. Vance R.E. Immunology taught by bacteria. J. Clin. Immunol. 2010, 30:507-511.
96. Vanderplasschen A., Mathew E., Hollinshead M., Sim R.B., Smith G.L. Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:7544-7549.
97. Vossen M.T., Westerhout E.M., Soderberg-Naucler C., Wiertz E.J. Viral immune evasion: a masterpiece of evolution. Immunogenetics 2002, 54:527-542.
98. Wiles A.P., Shaw G., Bright J., Perczel A., Campbell I.D., Barlow P.N. NMR studies of a viral protein that mimics the regulators of complement activation. J. Mol. Biol. 1997, 272:253-265.
99. Wu J., Morikis D. Molecular thermodynamics for charged biomacromolecules. Fluid Phase Equilib. 2006, 241:317-333.
100. Wu J., Wu Y.Q., Ricklin D., Janssen B.J., Lambris J.D., Gros P. Structure of complement fragment C3b-factor H and implications for host protection by complement regulators. Nat. Immunol. 2009, 10:728-733.
101. Yadav V.N., Pyaram K., Ahmad M., Sahu A. Species selectivity in poxviral complement regulators is dictated by the charge reversal in the central complement control protein modules. J. Immunol. 2012, 189:1431-1439.
102. Yadav V.N., Pyaram K., Mullick J., Sahu A. Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation. J. Virol. 2008, 82:3283-3294.
103. Zhang L., Mallik B., Morikis D. Immunophysical exploration of C3d-CR2(CCP1-2) interaction using molecular dynamics and electrostatics. J. Mol. Biol. 2007, 369:567-583.
104. Zhang L., Morikis D. Immunophysical properties and prediction of activities for VCP and SPICE using molecular dynamics and electrostatics. Biophys. J. 2006, 90:3106-3119.
105. Zipfel P.F., Skerka C. Complement regulators and inhibitory proteins. Nat. Rev. Immunol. 2009, 9:729-740.